Abstract:Abstract Immunosurveillance by Natural killer (NK) cells provides an efficient effector mechanism to eliminate tumor and virally infected cells. A well-defined characteristic of NK cells is their ability to lyse target cells deficient in MHC class I expression or target cells that express non-MHC ligands as a result of infection or transformation. This observation has been the basis for identification of a number of inhibitory and activatory NK cell receptors. Although the collective effort during the last decade shed light on the function of many NK cell receptors, the role of NCR1 in NK cell biology remains highly controversial. We have recently identified a spontaneous mutation of NCR1 in our C57BL/6 mouse colony. In this mutant, NCR1 expression was absent on conventional NK cells of all lymphoid organs as well as on innate lymphocytes (ILC3) of the gut lamina propria. Of note, NCR1 expression was absent on the surface as well as in the intracellular compartment of NK cells. Likewise, lack of NCR1 expression was confirmed in mixed BM chimera indicating a cell intrinsic phenotype. Only genetic backcrossing could correct the lack of NCR1 in these mice. ORF sequencing of NCR1 gene in mutant mice revealed a point mutation (C14R) in the region of signal peptide of NCR1 protein. However, while development and homeostasis of NK cells was not affected by the lack of NCR1, infection of NCR1C14R mutant mice with murine cytomegalovirus resulted in increased resistance, an advantage that correlated with NK cell hyperresponsive production of IFN-γ, but not cytotoxic activity. Moreover, NCR1 limits NK cell IFNγ response via regulation of Dok-1 phosphorylation and p38 activation. Collectively, our data reveal the role for NCR1 in IFNγ production of NK cell.

Author Correction: NK cell receptor NKG2D sets activation threshold for the NCR1 receptor early in NK cell development

Author Correction: CIS is a potent checkpoint in NK cell–mediated tumor immunity

Largely preserved functionality after the combined loss of NKG2D, NCR1 and CD16 demonstrates the remarkable plasticity of NK cell responsiveness

Author Correction: An organoid-based screen for epigenetic inhibitors that stimulate antigen presentation and potentiate T-cell-mediated cytotoxicity

Author Correction: T cell–encoded CD80 and 4-1BBL induce auto- and transcostimulation, resulting in potent tumor rejection

Publisher Correction: Network Inference from Glycoproteomics Data Reveals New Reactions in the IgG Glycosylation Pathway

RETRACTED: Corrigendum to “Lipopolysaccharide-Induced Podocyte Injury is Regulated by Calcineurin/nfat and TLR4/MyD88/NF-κB Signaling Pathways Through Angiopoietin-like Protein 4” [genes Dis DOI: 10.1016/J.gendis.2020.07.005]

Maintaining the Balance: Regulation of NK Cell Activity

Publisher Correction: Inhibition of LTβR Signalling Activates WNT-induced Regeneration in Lung

A spontaneous mutation in NCR1 locus reveals an inhibitory role for IFNγ response by NCR1 via inhibiting dok-1 phosphorylation

Correction: Corrigendum: The transcriptional coactivator TAZ regulates reciprocal differentiation of T H 17 cells and T reg cells

Author Correction: Drugging the NLRP3 inflammasome: from signalling mechanisms to therapeutic targets

Author Correction: IFN-γ is required for cytotoxic T cell-dependent cancer genome immunoediting

Corrigendum: Germline-Encoded TCR-MHC Contacts Promote TCR V Gene Bias in Umbilical Cord Blood T Cell Repertoire

Conditional NKT Cell Depletion in Mice Reveals a Negative Feedback Loop That Regulates CTL Cross-Priming

Corrigendum: Priming Is Dispensable for NLRP3 Inflammasome Activation in Human Monocytes In Vitro

Author Correction: BCG immunization induces CX3CR1 hi effector memory T cells to provide cross-protection via IFN-γ-mediated trained immunity

Author Correction: CAR-T cells targeting a nucleophosmin neoepitope exhibit potent specific activity in mouse models of acute myeloid leukaemia

A Human NK Cell Activation/Inhibition Threshold Allows Small Changes in the Target Cell Surface Phenotype To Dramatically Alter Susceptibility to NK Cells

NKG2A genetic deletion promotes human primary NK cell anti-tumor responses better than an anti-NKG2A monoclonal antibody

Erratum: Human pegivirus-1 replication influences NK cell reconstitution after allogeneic haematopoietic stem cell transplantation